When and not if sounds great, until you end up with a high average. Given how long you have followed this 13.5 is nice but definitely not a master stroke.
IMU $1.5bil MC, no revenue, high burn, lots of potential downside if things don't go their way.
- Forums
- ASX - By Stock
- RAP
- Ann: Pfizer raises scheme consideration to A$0.208 per share
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-34
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)